Biofrontera Share Price Today
(NASDAQ: BFRI)

Name: Biofrontera Share Price Today (NASDAQ: BFRI) - Biofrontera Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Biofrontera share price is $1 & ₹86.52 as on 20 Mar 2025, 2.30 'hrs' IST

▲

0.01

(1.32%)

Market is closed - opens 7 PM, 20 Mar 2025

View live Biofrontera share price in Dollar and Rupees. Guide to invest in Biofrontera stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biofrontera, along with analyst recommendations, forecasts, and comprehensive financials.

Biofrontera share price movements

Today's Low: $0.92
Today's High: $1.01
$1.00
8.0%
Downside
Day's Volatility :8.46%
Upside
0.5%
52 Weeks Low: $0.65
52 Weeks High: $2.43
$1.00
34.87%
Downside
52 Weeks Volatility :73.2%
Upside
58.85%

Biofrontera (BFRI) Returns

Period	Biofrontera Inc	Index (Russel 2000)
3 Months	-1.96%	0.0%
6 Months	-21.88%	0.0%
1 Year	-21.26%	0.0%
3 Years	-98.35%	-15.2%

Biofrontera (BFRI) Key Statistics

in dollars & INR

Previous Close	$0.987
Open	$0.97
Today's High	$1.00505
Today's Low	$0.92
Market Capitalization	$8.9M
Today's Volume	$83.9K
52 Week High	$2.4302
52 Week Low	$0.651266
Revenue TTM	$35.4M
EBITDA	$-18.9M
Earnings Per Share (EPS)	$1.18
PE Ratio	0.85
Profit Margin	-36.31%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-390.89%

How to invest in Biofrontera Stock (BFRI) from India?

It is very easy for Indian residents to invest directly in Biofrontera from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biofrontera stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biofrontera or BFRI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biofrontera or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biofrontera shares which would translate to 0.865 fractional shares of Biofrontera as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biofrontera, in just a few clicks!

Returns in Biofrontera (BFRI) for Indian investors in Rupees

The Biofrontera stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Biofrontera investment value today

Current value as on today

₹82,808

Returns

₹17,192

(-17.19%)

Returns from Biofrontera Stock

₹21,260 (-21.26%)

Dollar Returns

₹4,068 (+4.07%)

Indian investors sentiment towards Biofrontera (BFRI)

-41%

Period: Feb 17, 2025 to Mar 19, 2025. Change in 30 Days versus previous period

Search interest for Biofrontera Stock from India on INDmoney has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biofrontera

Rosalind Advisors, Inc.
9.15%
AIGH Capital Management, LLC
9.14%
Goldman Sachs Group Inc
0.51%
Virtu Financial LLC
0.50%
Scotia Capital Inc
0.28%
Geode Capital Management, LLC
0.22%

Analyst Recommendation on Biofrontera

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Biofrontera(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biofrontera Stock (BFRI)

What analysts predicted

Upside of 1050.0%

Target:

$11.50

Current:

$1.00

Insights on Biofrontera Stock (Ticker Symbol: BFRI)

Price Movement
In the last 3 years, BFRI stock has moved down by -98.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 7.83M → 9.01M (in $), with an average increase of 13.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -257.0K → -5.66M (in $), with an average decrease of 2105.8% per quarter
BFRI vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 95.7% return, outperforming this stock by 117.0%
BFRI vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 115.4% return, outperforming this stock by 213.7%
Price to Sales
ForBFRI every $1 of sales, investors are willing to pay $0.1, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

BFRI Biofrontera Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$26.2M	-
Net Income	$-11.0M	-
Net Profit Margin	-41.95%	-

	FY20	Y/Y Change
Revenue	$18.8M	↓ 28.01%
Net Income	$-11.0M	↑ 0.05%
Net Profit Margin	-58.29%	↓ 16.34%

	FY21	Y/Y Change
Revenue	$24.1M	↑ 27.86%
Net Income	$-37.7M	↑ 243.25%
Net Profit Margin	-156.49%	↓ 98.2%

	FY22	Y/Y Change
Revenue	$28.7M	↑ 18.98%
Net Income	$-640.0K	↓ 98.3%
Net Profit Margin	-2.23%	↑ 154.26%

	FY23	Y/Y Change
Revenue	$34.1M	↑ 18.82%
Net Income	$-20.1M	↑ 3045.47%
Net Profit Margin	-59.09%	↓ 56.86%

	Q2 FY23	Q/Q Change
Revenue	$5.8M	↓ 33.04%
Net Income	$-9.8M	↑ 31.55%
Net Profit Margin	-168.21%	↓ 82.58%

	Q3 FY23	Q/Q Change
Revenue	$8.9M	↑ 51.83%
Net Income	$-6.3M	↓ 35.53%
Net Profit Margin	-71.43%	↑ 96.78%

	Q4 FY23	Q/Q Change
Revenue	$10.6M	↑ 19.34%
Net Income	$3.5M	↓ 155.6%
Net Profit Margin	33.28%	↑ 104.71%

	Q1 FY24	Q/Q Change
Revenue	$7.9M	↓ 25.43%
Net Income	$-10.4M	↓ 396.0%
Net Profit Margin	-132.1%	↓ 165.38%

	Q2 FY24	Q/Q Change
Revenue	$7.8M	↓ 0.78%
Net Income	$-257.0K	↓ 97.54%
Net Profit Margin	-3.28%	↑ 128.82%

	Q3 FY24	Q/Q Change
Revenue	$9.0M	↑ 14.96%
Net Income	$-5.7M	↑ 2105.84%
Net Profit Margin	-62.91%	↓ 59.63%

	FY19	Y/Y Change
Profit	$13.8M	-

	FY20	Y/Y Change
Profit	$9.8M	↓ 28.97%

	FY21	Y/Y Change
Profit	$11.4M	↑ 16.1%

	FY22	Y/Y Change
Profit	$13.5M	↑ 18.76%

	FY23	Y/Y Change
Profit	$16.6M	↑ 23.26%

	Q2 FY23	Q/Q Change
Profit	$3.0M	↓ 28.42%

	Q3 FY23	Q/Q Change
Profit	$4.4M	↑ 48.11%

	Q4 FY23	Q/Q Change
Profit	$4.9M	↑ 12.52%

	Q1 FY24	Q/Q Change
Profit	$4.0M	↓ 19.83%

	Q2 FY24	Q/Q Change
Profit	$3.5M	↓ 11.58%

	Q3 FY24	Q/Q Change
Profit	$4.1M	↑ 18.24%

	FY19	Y/Y Change
Operating Cash Flow	$-37.7M	-
Investing Cash Flow	$25.4M	-
Financing Cash Flow	$16.4M	-

	FY20	Y/Y Change
Operating Cash Flow	$-12.4M	↓ 67.17%
Investing Cash Flow	$-11.0K	↓ 100.04%
Financing Cash Flow	$13.2M	↓ 19.55%

	FY21	Y/Y Change
Operating Cash Flow	$-26.7M	↑ 115.98%
Investing Cash Flow	$-11.0K	↑ 0.0%
Financing Cash Flow	$43.2M	↑ 227.35%

	FY22	Y/Y Change
Operating Cash Flow	$-16.2M	↓ 39.36%
Investing Cash Flow	$-5.2M	↑ 46772.73%
Financing Cash Flow	$14.0M	↓ 67.54%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-10.3M	↑ 180.18%
Investing Cash Flow	$178.0K	↑ 0.0%
Financing Cash Flow	$1.1M	↑ 0.0%

Biofrontera Technicals Summary

Sell

Neutral

Buy

Biofrontera is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Biofrontera (BFRI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biofrontera Inc	-13.04%	-21.88%	-21.26%	-98.35%	-98.87%
Intra-cellular Therapies, Inc.	2.79%	70.88%	95.7%	124.38%	888.2%
Haleon Plc Spon Ads	3.8%	-0.86%	25.85%	39.95%	39.95%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biofrontera Inc	0.85	0.85	NA	-2.98	-3.91	-0.46	NA	0.85
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	25.29	25.29	1.8	0.32	0.09	0.04	0.02	1.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biofrontera Inc	Buy	$8.9M	-98.87%	0.85	-36.31%
Intra-cellular Therapies, Inc.	Buy	$14.0B	888.2%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$46.9B	39.95%	25.29	12.84%

About Biofrontera

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Organization	Biofrontera
Employees	83
CEO	Dr. Hermann Luebbert Ph.D.
Industry	Miscellaneous

Management People of Biofrontera

Name	Title
Dr. Hermann Luebbert Ph.D.	CEO, President & Chairman
Mr. Eugene Frederick Leffler III	Chief Financial Officer
Ms. Erica F. Gates CPA, M.B.A.	Senior Director of Finance & Principal Accounting Officer
Mr. Jon Lyons M.B.A., Ph.D.	Vice President of Scientific & Medical Affairs
Mr. Daniel Hakansson J.D.	General Counsel & Head of Compliance

Important FAQs about investing in BFRI Stock from India :

What is Biofrontera share price today?

Biofrontera share price today stands at $1.00, Open: $0.97 ; Previous Close: $0.99 ; High: $1.01 ; Low: $0.92 ; 52 Week High: $2.43 ; 52 Week Low: $0.65.

The stock opens at $0.97, after a previous close of $0.99. The stock reached a daily high of $1.01 and a low of $0.92, with a 52-week high of $2.43 and a 52-week low of $0.65.

Can Indians buy Biofrontera shares?

Yes, Indians can invest in the Biofrontera (BFRI) from India.

With INDmoney, you can buy Biofrontera at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biofrontera at zero transaction cost.

How can I buy Biofrontera shares from India?

It is very easy to buy Biofrontera from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biofrontera (BFRI) be purchased?

Yes, you can buy fractional shares of Biofrontera with INDmoney app.

What are the documents required to start investing in Biofrontera stocks?

To start investing in Biofrontera, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.